Colombian medical cannabis company Clever Leaves has been granted Good Manufacturing Practice (GMP) certification by the Australian Therapeutic Goods Administration (TGA). The certification allows Clever Leaves to manufacture cannabis products for patients in Australia. GMP certification ensures the quality and safety of pharmaceutical products by safeguarding against issues such as contamination, compound variations, product mix-ups, and incorrect labelling. The certification is a prerequisite for manufacturing and commercialising cannabis products in the Australian market. According to TGA data, 325,000 new Australian patients commenced cannabis treatment in the first half of 2023, with 320,000 new patients in 2022 and 150,000 in 2021. Clever Leaves already distributes finished cannabis products in Australia through its partners.
Finance Colombia » Members of Indigenous Minga Take Over Lobby of Semana Magazine financecolombia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financecolombia.com Daily Mail and Mail on Sunday newspapers.
Doctors at Indiana University Health West Hospital in Avon, IN | US News Best Hospitals Rankings usnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from usnews.com Daily Mail and Mail on Sunday newspapers.
In an unprecedented move for the global medicinal cannabis market, Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) announced it has been granted an International Declaration of Carbon Neutrality by the 100% Carbon Neutral Program.